Disc Medicine, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
67.11
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
8
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-1.05
|
-0.89
|
0.16
|
15.38%
|
|
2024-06-30
|
-1.11
|
-1.03
|
0.08
|
7.21%
|
|
2024-03-31
|
-1.00
|
-1.09
|
-0.09
|
-9.00%
|
|
2023-12-31
|
-0.78
|
-0.90
|
-0.12
|
-15.38%
|
|
2023-09-30
|
-0.80
|
-0.58
|
0.22
|
27.50%
|
|
2023-06-30
|
-0.86
|
-0.74
|
0.12
|
13.95%
|
|
2023-03-31
|
-0.68
|
-1.20
|
-0.52
|
-76.47%
|
|
2022-12-31
|
-0.76
|
-1.22
|
-0.46
|
-60.53%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-3.01
|
|
2023-12-31
|
-3.42
|
|
2022-12-31
|
-6.40
|
|
2021-12-31
|
-18.10
|
|
2020-12-31
|
-2.07
|